Thresholding methods for PET imaging: A review;Les méthodes de seuillage en TEP : Un état de l'art

Medecine Nucleaire

Volumn 34, Issue 2, 2010, Pages 119-131

  Dewalle Vignion, A S ^a,b,c   El Abiad, A ^d   Betrouni, N ^a   Hossein Foucher, C ^b,c   Huglo, D ^a,b,c   Vermandel, M ^a,b,c  

^a INSERM   (France)

^b UNIV LILLE   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d ECOLE DES MINES DE NANTES   (France)

Author keywords

Positron emission tomography; Segmentation; SUV; Thresholding

Indexed keywords

ANALYTIC METHOD; COMPARATIVE STUDY; LITERATURE; METHODOLOGY; POSITRON EMISSION TOMOGRAPHY; SHORT SURVEY; TUMOR VOLUME;

EID: 78649931192     PISSN: 09281258     EISSN: 18786820     Source Type: Journal    
DOI: 10.1016/j.mednuc.2009.12.004     Document Type: Short Survey

References (42)

1. Berkowitz A., Basu S., Srinivas S., Sankaran S., Schuster S., Alavi A. Determination of whole-body metabolic burden as a quantitative measure of disease activity in lymphoma: a novel approach with fluorodeoxyglucose-PET. Nucl Med Comm 2008, 29:521-526.
2. Grégoire V., Haustermans K., Geets X., Roels S., Lonneux M. PET-based treatment planning in radiotherapy: a new standard?. J Med Nucl 2007, 48:68-77.
3. 18FDG-PET/CT on biological target volume (BTV) definition for treatment planning for non-small cell lung cancer patients. Nucl Instrum Methods Phys Res 2007, 571:89-92.
4. Nestle U., Kremp S., Grosu A.L. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): The technical basis, ICRU-target volumes, problems, perspectives. Radiother Oncol 2006, 81:209-225.
5. Erdi Y.E., Rosenzweig K., Erdi A.K., Macapinlac H.A., Hu Y.C., Braban L.E., et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol 2002, 62:51-60.
6. 18F-deoxyglucose positron-emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis. Int J Radiat Oncol Biol Phys 1999, 44:593-597.
7. Bachaud J.M., Marre D., Dygai I., Caselles O., Hamelin D., Bègue M., et al. Intérêt de la tomographie par émission de positons au [18F]-fluoro-2-désoxyglucose dans la détermination des volumes cibles de radiothérapie. Application à l'irradiation conformationnelle des cancers bronchiques non à petites cellules. Cancer Radiother 2005, 9:602-609.
8. Deniaud-Alexandre E. 18FDG et radiothérapie externe, le point de vue du radiothérapeute : application des techniques de fusion d'images à la radiothérapie des carcinomes bronchiques. Med Nucl 2008, 32:530-535.
9. Deniaud-Alexandre E., Touboul E., Lerouge D., Grahek D., Foulquier J.N., Petegnief Y., et al. Tomographie par émission de positons et détection en coïncidence (TEDC) et recalage d'images de simulation virtuelle par tomodensitométrie. Impact sur la planification de la radiothérapie conformationnelle des cancers bronchiques non à petites cellules. Cancer Radiother 2005, 9:304-315.
10. Green A.J., Francis R.J., Baig S., Begent R.H. Semiautomatic volume of interest drawing for (18)F-FDG image analysis-method and preliminary results. Eur J Nucl Med Mol Imaging 2008, 35:393-406.
11. Feng M., Kong F.M., Gross M., Fernando S., Hayman J.A., Ten Haken R.K. Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing. Int J Radiat Oncol Biol Phys 2009, 73:1228-1234.
12. 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2009, 73:756-763.
13. Gillham C., Zips D., Pönisch F., Evers C., Enghardt W., Abolmaali N., et al. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?. Radiother Oncol 2008, 88:335-341.
14. 18F-FDG PET images segmentation using morphological watershed: a phantom study. IEEE Nuclear Science Symposium Conference Record 2006, 2063-2067.
15. Drever L., Roa W., McEwan A., Robinson D. Comparison of three image segmentation techniques for target volume delineation in positron emission tomography. J Appl Clin Med Phys 2007, 8:93-109.
16. Bryant A.S., Cerfolio R.J. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules. Ann Thorac Surg 2006, 82:1016-1020.
17. Huglo D. Quantification de la fixation tumorale du fluoro-désoxyglucose [Quantification of fluoro-deoxyglucose tumor uptake]. Med Nucl 2002, 26:175-188.
18. Buvat I. Les limites du SUV. Med Nucl 2007, 31:165-172.
19. Erdi Y.E., Nehmed S.A., Pan T., Pevsner A., Rosenzweig K.E., Mageras G., et al. The CT motion quantitation of lung lesions and its impact on PET-measured SUVs. J Nucl Med 2004, 45:1287-1292.
20. Zasadny K.R., Kison P.V., Francis I.R., Wahl R.L. FDG-PET determination of metabolically active tumor volume and comparison with CT. Clin Positron Imaging 1998, 1:123-129.
21. Erdi Y.E., Mawlawi O., Larson S.M., Imbriaco M., Yeung H., Finn R., et al. Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding. Cancer 1997, 80:2505-2509.
22. Huglo D., Vermandel M., Rousseau J., Vasseur C., Steinling M. Limites des méthodes de seuillage pour la détermination des volumes en tomographie d'émission de positons. Med Nucl 2004, 28:155-162.
23. Miller T.R., Grigsby P.W. Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy. Int J Radiat Oncol Biol Phys 2002, 53:353-359.
24. Fernando S., Kong F., Kessler M., Chetty I., Narayan S., Tatro D., et al. Using FDG-PET to delineate gross tumor and internal target volumes. Int J Radiat Oncol Biol Phys 2005, 63:400-401.
25. Erdi Y.E., Wessels B.W., Loew M.H., Erdi A.K. Threshold estimation in single photon emission computed tomography and planar imaging for clinical radio-immunotherapy. Cancer Res 1995, 55:5823-5826.
26. Jentzen W., Freudenberg L., Eising E.G., Heinze M., Brandau W., Bockisch A. Segmentation of PET volumes by iterative image thresholding. J Nucl Med 2007, 48:108-114.
27. Daisne J.F., Sibomana M., Bol A., Doumont T., Lonneux M., Grégoire V. Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of the reconstruction algorithms. Radiother Oncol 2003, 69:247-250.
28. Daisne J.F., Duprez T., Weynand B., Lonneux M., Hamoir M., Reychler H., et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: Comparison between CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 2004, 233:93-100.
29. Black Q.C., Grills I.S., Kestin L.L., Wong C.Y.O., Wong J.W., Martinez A.A., et al. Defining a radiotherapy target with positron emission tomography. Int J Radiat Oncol Biol Phys 2004, 690:1272-1282.
30. 18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging 2007, 34:453-462.
31. Schaefer A., Kremp S., Hellwig D., Rube C., Kirsch C.M., Nestle U. A contrast-oriented algorithm for FDG-PET-based delineation of tumour volumes for the radiotherapy of lung cancer: derivation from phantom measurements and validation in patient data. Eur J Nucl Med Mol Imaging 2008, 35:1989-1999.
32. Nestle U., Kremp S., Schaefer-Schuler A., Sebastian-Welsch C., Hellwig D., Rube C., et al. Comparison of different methods for delineation of PET-positive tissue for target volume definition in radiotherapy of patients with non-small cell lung cancer. J Nucl Med 2005, 46:1342-1348.
33. 18F-FDG TEP-TDM en vue d'un traitement par radiothérapie. Med Nucl 2009, 33:440-449.
34. 18F-FDG TEP-TDM avec le volume de référence anatomopathologique dans les cancers bronchopulmonaires non à petites cellules. Med Nucl 2008, 32:339-353.
35. Ford E.C., Kinahan P.E., Hanlon L., Alessio A., Rajendran J., Schwartz D.L., et al. Tumor delineation using PET in head and neck cancers: Threshold contouring and lesion volumes. Med Phys 2006, 33:4280-4288.
36. Schwartz D.L., Ford E.C., Rajendran J., Yueh B., Coltrera M.D., Virgin J., et al. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: A pilot investigation. Head Neck 2005, 27:478-487.
37. Wang D., Bialkowski M., Schultz C.J., Jursinic P.A., Zhu X., Brown W., et al. FDG-PET/CT guided IMRT for head and neck carcinoma. Int J Radiat Oncol Biol Phys 2004, 60:519-520.
38. Fakhry N., Barberet M., Lussato D., Mundler O., Giovanni A., Zanaret M. Apport de la [18F]-FDG TEP/TDM dans la stadification initiale des cancers de la tête et du cou. Rev Laryngol Otol Rhinol 2007, 128:3-9.
39. Westerterp M., Van Westreenen H.L., Reitsma J.B., Hoekstra O.S., Stoker J., Fockens P., et al. Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy - Systematic review. Radiology 2005, 236:841-851.
40. 18F-FDG PET/CT in the restaging of esophageal cancer after surgical resection and radiotherapy. World J Gastroenterol 2009, 15:1836-1842.
41. Dwamena B.A., Sonnad S.S., Angobaldo J.O., Wahl R.L. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s - Meta-analytic comparison of PET and CT. Radiology 1999, 213:530-536.
42. Schinagl D.A., Hoffmann A.L., Vogel W.V., Van Dalen J.A., Verstappen S.M., Oyen W.J., et al. Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer?. Radiother Oncol 2009, 91:95-100.